AzTrials
AzTrials

Cat Dander AllergyNCT02050412

A Pilot Study for the Determination of Allergenicity of Cat Dander Samples Obtained by Different Methods

A study testing Cat fur scratch test in people with Cat Dander Allergy, run by Thomas Kuendig at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Measurement of skin reactivity of cat dander samples obtained by different methods. Subjects will be assessed for the study by of a conventional skin prick test with a positive (histamine), a positive (standardized cat dander extract) and a negative allergen control (a diluent) if they fulfil all other in- and… Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Cat Dander Allergy
What is being tested?
Cat fur scratch test
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteSwitzerland
Study dates
Feb 2014to Apr 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Written informed consent
  • Male or female between 18 years to 65 years
  • A positive clinical history with inhalant allergy presumably due to cat allergen.
  • Positive screening prick test (mean wheal diameter ≥ 3 mm) when tested with already standardized cat allergen extract.
  • Positive screening prick test (wheal diameter ≥ 3mm) to Histamine dihydrochloride 10mg/ml.

Who cannot join

  • Impaired in understanding the nature, meaning and scope of the study or incapable of giving written informed consent,
  • Participation in another clinical trial within the last 30 days and during the present study,
  • Pregnant or lactating women,
  • Positive skin reaction in the screening prick test to negative control,
  • Currently suffering from allergy symptoms,
  • History of systemic reactions to allergens,
Show all 11Show fewer
  • Severe diseases influencing the results of the present study by discretion of the investigator,
  • Immunotherapy with the allergen preparation during the past two years,
  • Skin lesions and excessive hair-growth in the skin test areas,
  • Treatment with prohibited concomitant medications according to section 9.3 (protocol) with the exception of medications with local effects which will not influence the results of the skin tests,
  • Alcohol or drug abuse.

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Clinical Trials Center, University Hospital and University Zurich

    Zurich, Canton of Zurich, 8091

Other trials in Switzerland

About this study

Measurement of skin reactivity of cat dander samples obtained by different methods.

Subjects will be assessed for the study by of a conventional skin prick test with a positive (histamine), a positive (standardized cat dander extract) and a negative allergen control (a diluent) if they fulfil all other in- and exclusion criteria, too.

Read more

A screening prick test will be performed in order to confirm positivity (cat dander allergy).

A scratch test will be performed in participants after a positive screening prick test, in order to measure skin reactivity to cat dander, originating of three different body areas of the cat. For this purpose, a small amount of cat fur in solution with distilled water will be placed onto the volar aspect of both forearms after the skin has been scratched with a scratch lancet. The distilled water in which the cat hair was solved before will serve as negative control.

This procedure will be repeated with fur of the three different areas of the cat, always using triplicates (nine samples per cat).

From each of the 20 cats, nine samples will be tested on 20 subjects (one cat/subject).

Being tested
Cat fur scratch test

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cat fur scratch testOther

Study groups in NCT02050412
Study groupRoleWhat they receive
Cat fur scratch testOtherNot described
Receives: Other: Cat fur scratch test

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The primary variable will be the wheal size area of the immediate phase reaction in mm²

    Measured: measured after 15 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jan 2014 (estimated)
  2. Study startFeb 2014
  3. Primary completionMar 2014
  4. Study completionApr 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02050412
Sponsor's protocol ID
ZU-Scratch-Cat-001
Status last verified
Apr 2014
First submitted
28 Jan 2014
Last updated
10 Apr 2014
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing Cat fur scratch test in people with Cat Dander Allergy, run by Thomas Kuendig at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Apr 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The primary variable will be the wheal size area of the immediate phase reaction in mm² (time frame: measured after 15 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Apr 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in